These results suggest that MLL4 functions as a key transcriptional activator that induces the expression of pro-inflammatory M1 genes through LPS-dependent NF-κB transactivation, which promotes NASH progression. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.